Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 11

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Elucidating the Mechanisms of R248Q Mutation-Enhanced p53 Aggregation and Its Inhibition by Resveratrol

Liu, Qian, Li, Le, Yu, Yawei, Wei, Guanghong · 2023 · The Journal of Physical Chemistry B

Abstract

Aggregation of p53 mutants can result in loss-of-function, gain-of-function, and dominant-negative effects that contribute to tumor growth. Revealing the mechanisms underlying mutation-enhanced p53 aggregation and dissecting how small molecule inhibitors prevent the conversion of p53 into aggregation-primed conformations are fundamentally important for the development of novel therapeutics for p53 aggregation-associated cancers. A recent experimental study shows that resveratrol (RSV) has an inhibitory effect on the aggregation of hot-spot R248Q mutant of the p53 core domain (p53C), while pterostilbene (PT) exhibits a relatively poor inhibitory efficacy. However, the conformational properties of the R248Q mutant leading to its enhanced aggregation propensity and the inhibitory mechanism of RSV against p53C aggregation are not well understood. Herein, we performed extensive all-atom molecular dynamics simulations on R248Q p53C in the absence and presence of RSV/PT, as well as wild-type (WT) p53C. Our simulations reveal that loop L3, where the mutation resides, remains compact in WT p53C, while it becomes extended in the R248Q mutant. The extension of loop L3 weakens the interactions between loop L3 and two crucial aggregation-prone regions (APRs) of p53C, leading to impaired interactions within the APRs and their structural destabilization as well as p53C. The destabilized APRs in the R248Q mutant are more exposed than in WT p53C, which is conducive to p53C aggregation. RSV has a higher preference to bind to R248Q p53C than PT. This binding not only stabilizes loop L3 of R248Q mutant to its WT-like conformation, preventing L3-extension-caused APRs' destabilization but also reduces APRs' solvent exposure, thereby inhibiting R248Q p53C aggregation. However, PT exhibits a lower hydrogen-bonding capability and a higher self-association propensity, which would lead to a reduced p53C binding and a weakened inhibitory effect on R248Q mutant aggregation. Our study provides mechanistic insights into the R248Q mutation-enhanced aggregation propensity and RSV's potent inhibition against R248Q p53C aggregation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jpcb.3c04700

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 69

  1. 10.1016/j.cell.2017.08.028 · DOI · Paper page
  2. 10.1007/BF00690207 · DOI · Paper page
  3. 10.1038/s41573-022-00571-8 · DOI · Paper page
  4. 10.1016/j.tcb.2009.10.002 · DOI · Paper page
  5. 10.1002/humu.20495 · DOI · Paper page
  6. 10.1146/annurev.biochem.77.060806.091238 · DOI · Paper page
  7. 10.1038/sj.onc.1203434 · DOI · Paper page
  8. 10.1146/annurev-biochem-060815-014710 · DOI · Paper page
  9. 10.1038/nchembio.546 · DOI · Paper page
  10. 10.1016/j.ccell.2020.11.013 · DOI · Paper page
  11. 10.1038/s41467-021-23985-1 · DOI · Paper page
  12. 10.1021/acs.accounts.7b00473 · DOI
  13. 10.1074/jbc.M112.340638 · DOI · Paper page
  14. 10.1021/bi034218k · DOI · Paper page
  15. 10.1186/s40164-022-00317-7 · DOI · Paper page
  16. 10.4161/pri.27776 · DOI
  17. 10.1016/j.tibs.2014.04.001 · DOI · Paper page
  18. 10.1016/j.biocel.2010.10.017 · DOI · Paper page
  19. 10.1016/j.bbrc.2012.11.130 · DOI
  20. 10.1128/MCB.24.8.3536-3551.2004 · DOI · Paper page
  21. 10.1016/0092-8674(91)90384-B · DOI · Paper page
  22. 10.1016/j.isci.2020.100820 · DOI
  23. 10.1038/cdd.2017.105 · DOI
  24. 10.1073/pnas.1500262112 · DOI · Paper page
  25. 10.18632/oncotarget.25631 · DOI
  26. 10.1016/j.bpj.2022.10.013 · DOI
  27. 10.1038/cdd.2013.17 · DOI · Paper page
  28. 10.1038/cddis.2014.75 · DOI
  29. 10.1073/pnas.2015618118 · DOI
  30. 10.1073/pnas.1700308114 · DOI · Paper page
  31. 10.1038/35094077 · DOI · Paper page
  32. 10.1074/jbc.RA118.004671 · DOI
  33. 10.1021/acs.chemrev.0c01122 · DOI · Paper page
  34. 10.1016/j.jnutbio.2005.01.017 · DOI · Paper page
  35. 10.3390/molecules22061014 · DOI
  36. 10.1021/ja8097417 · DOI
  37. 10.1074/jbc.M110.133108 · DOI · Paper page
  38. 10.1016/j.bbapap.2017.02.014 · DOI
  39. 10.1093/nar/gky1314 · DOI
  40. 10.1038/ncomms2361 · DOI · Paper page
  41. 10.1021/acschembio.9b00748 · DOI · Paper page
  42. 10.1039/C9CP06671C · DOI
  43. 10.1039/D1CP03094A · DOI · Paper page
  44. 10.1042/BCJ20190778 · DOI
  45. 10.1021/acs.jpcb.6b07457 · DOI
  46. 10.1021/acs.jcim.2c00380 · DOI
  47. 10.1016/j.celrep.2022.110622 · DOI · Paper page
  48. 10.1016/j.chembiol.2022.07.003 · DOI
  49. 10.1039/D1CP05670K · DOI
  50. 10.1016/j.jmb.2021.167048 · DOI
  51. 10.1038/s41467-021-21258-5 · DOI
  52. 10.1016/j.bpj.2022.03.030 · DOI
  53. 10.1158/1535-7163.MCT-22-0008 · DOI
  54. 10.1021/acs.jpcb.1c05638 · DOI
  55. Information. N. C. f. B. PubChem. Compound Summary for CID 445154, Resveratrol. https://pubchem.ncbi.nlm.nih.gov/compound/Resveratrol (accessed).
  56. Information. N. C. f. B. PubChem. Compound Summary for CID 5281727, Pterostilbene. https://pubchem.ncbi.nlm.nih.gov/compound/Pterostilbene (accessed).
  57. 10.1016/j.softx.2015.06.001 · DOI · Paper page
  58. 10.1038/nmeth.4067 · DOI · Paper page
  59. 10.1063/1.445869 · DOI · Paper page
  60. 10.1002/jcc.20290 · DOI · Paper page
  61. 10.1002/jcc.20035 · DOI · Paper page
  62. 10.1063/1.2408420 · DOI · Paper page
  63. 10.1080/00268978300102851 · DOI · Paper page
  64. 10.1063/1.464397 · DOI · Paper page
  65. 10.1002/bip.360221211 · DOI · Paper page
  66. 10.1126/science.3892686 · DOI · Paper page
  67. 10.1096/fj.01-0442hyp · DOI · Paper page
  68. 10.1074/jbc.RA118.003285 · DOI
  69. 10.1073/pnas.1211550109 · DOI · Paper page

Cited by

Metadata

Authors
Liu, Q., Li, L., Yu, Y., & Wei, G.
Affiliations
Department of Physics, State Key Laboratory of Surface Physics, and Key Laboratory for Computational Physical Sciences (Ministry of Education), Fudan University, Shanghai 200438, People’s Republic of China
Venue
The Journal of Physical Chemistry B
Published
2023-09-04
Volume
127
Issue
36
Pages
7708-7720
ISSN
  • 1520-6106
  • 1520-5207
Cited by
11
References
10
Language
en
Funders
  • Natural Science Foundation of Shanghai (22ZR1406800)
  • National Natural Science Foundation of China (12074079)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.